Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-015-1229-6
Published Online: 2015-04-03
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Grek, Christina L
Rhett, Joshua Matthew
Bruce, Jaclynn S
Abt, Melissa A
Ghatnekar, Gautam S
Yeh, Elizabeth S
License valid from 2015-04-03
Article History
Received: 3 October 2014
Accepted: 19 March 2015
First Online: 3 April 2015